Putting the evidence side by side Here is the blunt comparison: AOD 9604: 2.6 kg weight loss in 12 weeks (best result), failed six clinical trials, development terminated Semaglutide: 15 to 17 percent body weight loss over 68 weeks, FDA approved, thousands of study participants, consistent results across multiple trials There is no way to frame this comparison that puts AOD 9604 on equal footing with semaglutide when it comes to clinical evidence
Understanding 5-Amino-1MQ 5-Amino-1MQ, short for 5-Amino-1-methylquinolin-2(1H)-one, is a synthetic compound with significant anti-aging effects in preclinical studies
First-time users or those with sensitive constitutions are recommended to start at 50 mg daily for 12 weeks to observe body tolerance
Nicotinamide N-methyltransferase: more than a vitamin B3 clearance enzyme
Methionine and choline help the body process and remove fat from the liver, inositol assists with fat transport and mood regulation, and B12 promotes red blood cell production and helps convert food into usable energy
Retatrutide (weight loss - investigational) Article: Retatrutide for Weight Loss (Investigational) Retatrutide is an experimental peptide that activates three metabolic receptorsGLP-1 (reduces appetite, slows digestion), GIP (improves insulin response) and glucagon (burns fat and calories)
